KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Dividends Paid - Common (2016 - 2025)

AbbVie (ABBV) has disclosed Dividends Paid - Common for 13 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • Quarterly Dividends Paid - Common rose 5.78% to $2.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.7 billion through Dec 2025, up 5.73% year-over-year, with the annual reading at $11.7 billion for FY2025, 5.73% up from the prior year.
  • Dividends Paid - Common for Q4 2025 was $2.9 billion at AbbVie, roughly flat from $2.9 billion in the prior quarter.
  • The five-year high for Dividends Paid - Common was $2.9 billion in Q1 2025, with the low at $2.3 billion in Q2 2021.
  • Average Dividends Paid - Common over 5 years is $2.6 billion, with a median of $2.6 billion recorded in 2023.
  • The sharpest move saw Dividends Paid - Common soared 31.85% in 2021, then grew 4.17% in 2024.
  • Over 5 years, Dividends Paid - Common stood at $2.3 billion in 2021, then grew by 8.3% to $2.5 billion in 2022, then grew by 4.79% to $2.6 billion in 2023, then increased by 4.8% to $2.8 billion in 2024, then rose by 5.78% to $2.9 billion in 2025.
  • According to Business Quant data, Dividends Paid - Common over the past three periods came in at $2.9 billion, $2.9 billion, and $2.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.